---

March 06, 2023

Predictmedix Announces a Purchase Order for Safe Entry’s Fit for Duty Screening in the Defence Sector

DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry’s impairment detection screening   Each of the four Safe Entry Station’s to generate…

Read full release →

February 15, 2023

Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare

Toronto, Ontario, February 15, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal…

Read full release →

February 13, 2023

Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange

Toronto, Ontario, February 13, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announces that it…

Read full release →

January 16, 2023

Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023

Toronto, Ontario, January 16, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced a corporate…

Read full release →

November 17, 2022

Predictmedix Deploys Safe Entry’s Fit for Duty Screening at LongArm Engineering

LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the…

Read full release →